GlassScriptPhysician profile
Apoorva R Vashi
NPI 1588705354
$4,036.99
in general payments reported to CMS, 2019-2025
33 companies · $855 in 2025
The $855 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $505 · 2021: $363 · 2022: $259 · 2023: $693 · 2024: $492 · 2025: $855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,039.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $954.59 | 2019-2024 | Lithovue, Gateway Advantage, Lumenis Pulse 120h |
| Pfizer INC. | $597.08 | 2019-2025 | |
| Neotract INC. | $546.74 | 2019-2020 | |
| Dornier Medtech America, INC | $227.36 | 2025 | Dornier Medtech |
| Teleflex LLC | $225.33 | 2021-2025 | Barrigel |
| Procept Biorobotics Corporation | $174.90 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Calyxo, INC. | $156.52 | 2024-2025 | Cvac Aspiration System |
| Axonics, INC. | $153.88 | 2023 | Axonics, Bulkamid |
| Karl Storz Endoscopy-America | $152.50 | 2019 | |
| Astellas Pharma US INC | $116.14 | 2019-2023 | Myrbetriq |
| Janssen Biotech, INC. | $109.45 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $100.28 | 2022-2024 | Lynparza, Keytruda |
| Angiodynamics, INC. | $71.13 | 2022-2025 | Nanoknife |
| Urogen Pharma, INC. | $48.17 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $40.19 | 2022-2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $39.04 | 2019-2024 | |
| Rochester Medical Corporation | $29.78 | 2020 | |
| Olympus America INC. | $29.65 | 2021-2023 | Itind System |
| Coloplast Corp | $27.73 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $25.78 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $24.62 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $23.75 | 2019 | |
| Biotissue Holdings INC. | $23.07 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $19.47 | 2022 | |
| Srs Medical Systems, INC. | $18.31 | 2020 | |
| Ferring Pharmaceuticals INC. | $15.72 | 2025 | Adstiladrin |
| Amgen INC. | $14.69 | 2019 | |
| Agiliti Surgical, INC. | $14.64 | 2024 | Lasers |
| Innovation Technologies INC | $14.17 | 2025 | Irrisept |
| C. R. Bard, INC. & Subsidiaries | $12.11 | 2019 | |
| Antares Pharma, INC. | $11.89 | 2022 | |
| Travere Therapeutics, INC. | $10.44 | 2019 | |
| Aroa Biosurgery Incorporated | $7.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apoorva Vashi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.